Multilayer network analysis of the drugs development cycle in the global pharmaceutical industry
暂无分享,去创建一个
[1] B. Munos. Lessons from 60 years of pharmaceutical innovation , 2009, Nature Reviews Drug Discovery.
[2] F. Scherer. Chapter 12 – Pharmaceutical Innovation , 2010 .
[3] R. K. Pati,et al. Managerial research on the pharmaceutical supply chain - A critical review and some insights for future directions , 2014 .
[4] Martin Rosvall,et al. Multilevel Compression of Random Walks on Networks Reveals Hierarchical Organization in Large Integrated Systems , 2010, PloS one.
[5] F. Scherer,et al. Mergers and innovation in the pharmaceutical industry. , 2013, Journal of health economics.
[6] 眞里 治部,et al. 日本版NIH創設に向けた新しい指標の開発(4) パイプラインにつながる特許の判別指標 , 2014 .
[7] 眞里 治部,et al. AMED(日本版NIH)創設に向けた新しい指標の開発(8) 医薬品研究開発における知識の流れ , 2014 .
[8] Andrea Lancichinetti,et al. Community detection algorithms: a comparative analysis: invited presentation, extended abstract , 2009, VALUETOOLS.
[9] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[10] Guanrong Chen,et al. A two-level complex network model and its application , 2009 .
[11] Nic Fleming,et al. How artificial intelligence is changing drug discovery , 2018, Nature.
[12] 青山 秀明,et al. Econophysics and companies : statistical life and death in complex business networks , 2011 .
[13] Martin Rosvall,et al. Maps of random walks on complex networks reveal community structure , 2007, Proceedings of the National Academy of Sciences.
[14] 眞里 治部,et al. 日本版NIH創設に向けた新しい指標の開発(2) テクノロジー別にみた医薬品開発の現状俯瞰・将来予測 , 2013 .
[15] 眞里 治部,et al. AMED(日本版NIH)創設に向けた新しい指標の開発(7) 米国のファンディング動向 , 2014 .
[16] Jürgen Kurths,et al. Investigating the topology of interacting networks , 2011, 1102.3067.
[17] 眞里 治部,et al. AMED(日本版NIH)創設に向けた新しい指標の開発(6) 疾病別にみた医薬品開発の現状俯瞰・将来予測 , 2014 .
[18] 眞里 治部,et al. 日本版NIH創設に向けた新しい指標の開発(5) パイプラインにつながる特許判別指標の応用 , 2014 .
[19] M. Bruccoleri,et al. Supply chain of innovation and new product development , 2015 .
[20] Patrick Thiran,et al. Layered complex networks. , 2006, Physical review letters.
[21] Yoshi Fujiwara,et al. Econophysics and Companies: Contents , 2010 .
[22] 眞里 治部,et al. 日本版NIH創設に向けた新しい指標の開発(1) 新しい指標に基づいた医薬品産業の現状俯瞰・将来予測 , 2013 .
[23] Yoshi Fujiwara,et al. Econophysics and Companies: List of figures , 2010 .
[24] D. Hand. Econophysics and Companies: Statistical Life and Death in Complex Business Networks by Hideaki Aoyama, Yoshi Fujiwara, Yuichi Ikeda, Hiroshi Iyetomi, Wataru Souma , 2010 .
[25] G. Bianconi. Statistical mechanics of multiplex networks: entropy and overlap. , 2013, Physical review. E, Statistical, nonlinear, and soft matter physics.
[26] D. He,et al. Topological relation of layered complex networks , 2010 .
[27] Harry Eugene Stanley,et al. Catastrophic cascade of failures in interdependent networks , 2009, Nature.
[28] Andrei Z. Broder,et al. Graph structure in the Web , 2000, Comput. Networks.